[go: up one dir, main page]

AU2001266653A1 - Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption - Google Patents

Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption

Info

Publication number
AU2001266653A1
AU2001266653A1 AU2001266653A AU6665301A AU2001266653A1 AU 2001266653 A1 AU2001266653 A1 AU 2001266653A1 AU 2001266653 A AU2001266653 A AU 2001266653A AU 6665301 A AU6665301 A AU 6665301A AU 2001266653 A1 AU2001266653 A1 AU 2001266653A1
Authority
AU
Australia
Prior art keywords
modulator
consumption
potassium channel
dependent potassium
conductance calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266653A
Inventor
Andrew G. Davies
Hongkyun Kim
Steven L. Mcintire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001266653A1 publication Critical patent/AU2001266653A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001266653A 2000-06-02 2001-06-01 Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption Abandoned AU2001266653A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20943200P 2000-06-02 2000-06-02
US60209432 2000-06-02
PCT/US2001/017812 WO2001094375A1 (en) 2000-06-02 2001-06-01 Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption

Publications (1)

Publication Number Publication Date
AU2001266653A1 true AU2001266653A1 (en) 2001-12-17

Family

ID=22778729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266653A Abandoned AU2001266653A1 (en) 2000-06-02 2001-06-01 Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption

Country Status (2)

Country Link
AU (1) AU2001266653A1 (en)
WO (1) WO2001094375A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10243599A1 (en) 2002-09-19 2004-04-01 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Measuring device and method for a screening of cells immobilized on electrodes

Also Published As

Publication number Publication date
WO2001094375A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU2635201A (en) Direct manipulation of displayed content
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001283492A1 (en) Methods of patterning protein and cell adhesivity
AU2001291859A1 (en) Use of copolycarbonates
AU1525101A (en) Absorbent bodies for applying to skin and mucusa surfaces
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001274817A1 (en) Agents that modulate dna-pk activity and methods of use thereof
AU2002255451A1 (en) Procaryotic libraries and uses
AU2001286976A1 (en) Novel autoinducer molecules and uses therefor
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001271266A1 (en) Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
AU2001267428A1 (en) Direct detection of individual molecules
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2002216223A1 (en) Preservation of cells
AU5319999A (en) Novel potassium channel molecules and uses therefor
AU2001278155A1 (en) Fermentation and purification of mycolactones
AU2001244676A1 (en) Gene concerning brassinosteroid-sensitivity of plants and utilization thereof
AU2001280646A1 (en) Display and method of manufacture
AU2001283872A1 (en) Regulation of human eosinophil serine protease 1-like enzyme
AU3509100A (en) Novel potassium channel molecules and uses therefor
AU2001266653A1 (en) Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use